{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06100263",
            "orgStudyIdInfo": {
                "id": "UMCC 2023.092"
            },
            "secondaryIdInfos": [
                {
                    "id": "HUM00244376",
                    "type": "OTHER",
                    "domain": "University of Michigan"
                }
            ],
            "organization": {
                "fullName": "University of Michigan Rogel Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Breast Cancer Resiliency Through Exercise Program (B-REP)",
            "officialTitle": "Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study",
            "acronym": "B-REP",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "breast-cancer-resiliency-through-exercise-program-b-rep"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-20",
            "studyFirstSubmitQcDate": "2023-10-20",
            "studyFirstPostDateStruct": {
                "date": "2023-10-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Michigan Rogel Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and a health education control among 60 Black breast cancer survivors."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer Female"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intervention (Supervised exercise)",
                    "type": "EXPERIMENTAL",
                    "description": "The individualized resistance exercise program is based on participants' baseline 1-repetition maximum muscular strength assessment (i.e., the maximum lifted for 1 repetition) and is aligned with current cancer-specific exercise recommendations. The resistance exercise program will follow the FITT principle (frequency, intensity, time, and type). Sessions will be 35-45 minutes in duration.",
                    "interventionNames": [
                        "Other: Individualized exercise program"
                    ]
                },
                {
                    "label": "Control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants randomized to health education control condition will receive the American Cancer Society Physical Activity and the Person with Cancer summary for patients and American College of Sports Medicine Exercise is Medicine Effects of Exercise on Health-Related Outcomes in Those with Cancer infographic",
                    "interventionNames": [
                        "Other: Control Arm"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Individualized exercise program",
                    "description": "guided exercise program for 12 weeks",
                    "armGroupLabels": [
                        "Intervention (Supervised exercise)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Control Arm",
                    "description": "American Cancer Society Physical Activity and the Person with Cancer summary for patients will be provided",
                    "armGroupLabels": [
                        "Control"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Feasibility of the exercise program (Retention)",
                    "description": "Percent of patients that complete the intervention",
                    "timeFrame": "up to 24 weeks after start of intervention"
                },
                {
                    "measure": "Feasibility of the exercise program (Adherence)",
                    "description": "Percent of patients that complete the exercise sessions",
                    "timeFrame": "12 weeks after start of intervention"
                },
                {
                    "measure": "Feasibility of the exercise program (fidelity)",
                    "description": "Upon completion of the trial, a random sample of 10 recorded sessions will be analyzed for fidelity. Research staff who did not conduct the intervention will use a \"fidelity checklist\" of specific exercises and intervention characteristics (e.g., allowing time for questions, cueing for proper posture and form, etc.) required for each exercise session..",
                    "timeFrame": "12 weeks after start of intervention"
                },
                {
                    "measure": "Satisfaction of program",
                    "description": "14-item scale measuring ease of use, convenience, engagement, enjoyment, and privacy elements of the intervention.",
                    "timeFrame": "up to 24 weeks after start of intervention"
                },
                {
                    "measure": "Affective attitude",
                    "description": "36-item scale assessing views, attitude, and experiences in exercise87",
                    "timeFrame": "up to 24 weeks after start of intervention"
                },
                {
                    "measure": "Perceived burden",
                    "description": "Single item, \"Now that you've completed this part of the study, how burdensome or difficult did you find the experience. Select the response that best represents your experience.\" (1= Very burdensome to 5= Not too burdensome.)",
                    "timeFrame": "up to 24 weeks after start of intervention"
                },
                {
                    "measure": "Outcome expectation",
                    "description": "15-item scale assessing physical, social, and self-evaluative outcomes of exercise",
                    "timeFrame": "up to 24 weeks after start of intervention"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nWomen will be eligible if they meet the following criteria:\n\n* self-identify as Black or African American or Afro-Latina/e;\n* are \u226518 years old;\n* have a confirmed diagnosis of breast cancer, Stage 0I to IIIA;\n* have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;\n* are not meeting current cancer-specific resistance exercise guidelines of \u2265 2 times per week; and\n* are able to speak and understand English.\n\nExclusion Criteria:\n\n* metastatic disease;\n* medical reason that precludes them from increasing current exercise levels;\n* planned elective surgery during study period;\n* pregnant or plans to become pregnant during the study period;\n* plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States);\n* current enrollment in another exercise trial; and/or\n* inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Cancer AnswerLine",
                    "role": "CONTACT",
                    "phone": "1-800-865-1125",
                    "email": "CancerAnswerLine@med.umich.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Angela Fong, PhD",
                    "affiliation": "University of Michigan Rogel Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cancer AnswerLine",
                            "role": "CONTACT",
                            "phone": "800-865-1125",
                            "email": "CancerAnswerLine@med.umich.edu"
                        },
                        {
                            "name": "Angela Fong, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}